The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
TREM2 in CNS homeostasis and neurodegenerative disease
Open accessAbstract
Myeloid-lineage cells accomplish a myriad of homeostatic tasks including the recognition of pathogens, regulation of the inflammatory milieu, and mediation of tissue repair and regeneration. The innate immune receptor and its adaptor protein—triggering receptor expressed on myeloid cells 2 (TREM2) and DNAX-activating protein of 12 kDa (DAP12)—possess the ability to modulate critical cellular functions via crosstalk with diverse signaling pathways. As such, mutations in TREM2 and DAP12 have been found to be associated with a range of disease phenotypes. In particular, mutations in TREM2 increase the risk for Alzheimer's disease and other neurodegenerative disorders. The leading hypothesis is that microglia, the resident immune cells of the central nervous system, are the major myeloid cells affected by dysregulated TREM2-DAP12 function. Here, we review how impaired signaling by the TREM2-DAP12 pathway leads to altered immune responses in phagocytosis, cytokine production, and microglial proliferation and survival, thus contributing to disease pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 The TREM2-DAP12 axis modulates homeostatic functions via crosstalk with diverse signaling pathways. In the CNS, TREM2-DAP12 is preferentially expressed within microglia [32, 33]. Although signaling events need to be sequentially validated in microglia that endogenously express TREM2-DAP12, genetic depletion experiments in vitro support a multi-faceted role for TREM2-DAP12 in CNS homeostasis; TREM2-DAP12 suppresses inflammatory cytokine production following PRR-mediated recognition of PAMPs/DAMPs. LPS stimulation induces DAP12-dependent phosphorylation of Dok3 which is then recruited to the plasma membrane. There, pDok3 binds Grb2 and Sos1, thus preventing the activation of RAS and ERK, as well as the subsequent production of pro-inflammatory cytokines [68]. Similar to full-length TREM2, expression of only the TREM2-CTF leads to DAP12-dependent anti-inflammatory effects [67]. TREM2-DAP12 facilitates phagocytosis of PAMPs/DAMPs and promotes cellular debris clearance following injury or insult. Src kinase phosphorylation of the tyrosine residues of the DAP12 ITAM domain creates a docking site for Syk and downstream activation of the guanine nucleotide exchange factors Vav2/3 [74, 75] which are capable of activating Rac1/Cdc42-dependent phagocytosis and regulation of the actin cytoskeleton [60]. TREM2-DAP12 signaling synergizes with that of CSF-1R to induce a transcriptional profile reflective of enhanced myeloid cell proliferation and reduced cell death. CSF-1 via CSF-1R induces phosphorylation of DAP12 by Src kinases associated with tyrosine residue 559 of the CSF-1R, followed by DAP12-dependent phosphorylation of Syk and subsequent Pyk2-dependent activation of β-catenin-regulated pro-survival pathways [80, 81]](https://figures.cochat.ai/paper-figures/ab3fb3064b2b47568670c0b5a782f481/trem2-in-cns-homeostasis-and-neurodegenerative-disease-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In microglia, TREM2-DAP12 induces an M2-like activation44 and participates in recognition of membrane debris and amyloid deposits resulting in microglial activation and proliferation45-47.”
From Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) · cites this paper as [45]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“One of the downstream pathways of TREM2-TYROBP is small GTPases in the Ras-homologous (Rho) family (e.g., Cdc42, Rac) (49, 50).”
From The effect of Abi3 locus deletion on the progression of Alzheimer’s disease-related pathologies (2023) · cites this paper as [50]
In the citing paper
“TREM2 inhibits pro-inflammatory cytokine production, facilitates phagocytosis and promotes cell survival. Thus, TREM2 dysfunction could induce the loss of the homeostasis in the tissue (Painter et al., 2015).”
From The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma. (2017) · cites this paper as Painter et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459
Self-citationHarold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Cited by
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
ARUK Consortium, Sims, R., GERAD/PERADES, C., van der Lee, S. J., Naj, A. C., Bellenguez, C., Badarinarayan, N., Jakobsdottir, J., Kunkle, B. W., Boland, A., et al. (2017) · Nature Genetics · doi:10.1038/ng.3916 · Cited by 1,012
Inflammatory Response in the CNS: Friend or Foe?
Sochocka, M., Diniz, B. S., & Leszek, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0297-1 · Cited by 573
The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma.
Ramirez, A. I., de Hoz, R., Salobrar-Garcia, E., Salazar, J. J., Rojas, B., Ajoy, D., López-Cuenca, I., Rojas, P., Triviño, A., & Ramírez, J. M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00214 · Cited by 466
The role of astrocytes in amyloid production and Alzheimer's disease
Frost, G. R., & Li, Y.-M. (2017) · Open Biology · doi:10.1098/rsob.170228 · Cited by 435
Metadata
- Authors
- Painter, M. M., Atagi, Y., Liu, C.-C., Rademakers, R., Xu, H., Fryer, J. D., & Bu, G.
- Affiliations
- Mayo Clinic (US)
- Xiamen University (CN)
- Corresponding author
- Bu, Guojun
- Venue
- Molecular Neurodegeneration
- Published
- 2015-09-04
- Volume
- 10
- Issue
- 1
- Pages
- 43-43
- ISSN
- 1750-1326 (ISSN-L)
- PMC
- PMC4560063
- OpenAlex
- W2117601071
- Cited by
- 169
- References
- 86
- Citations by year
- 2026: 12 · 2025: 19 · 2024: 19 · 2023: 11 · 2022: 22 · 2021: 20 · 2020: 7 · 2019: 11 · 2018: 18 · 2017: 22 · 2016: 7 · 2015: 1
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- Molecular Neurodegeneration (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
- Funders
- National Institutes of Health (ID0EHHAE325, R01AG035355, ID0EDQAE327, ID0ERUAE328, ID0E6YAE329, ID0EN4AE330)
- Alzheimer's Association (ID0E3BAG331)
- Cure Alzheimer's Fund (ID0EIGAG332)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- TREM2, DAP12, microglia, neurodegenerative diseases, Alzheimer's disease, innate immunity, phagocytosis, cytokine production, myeloid cells, CNS homeostasis
- MeSH terms
- Alzheimer Disease, Animals, Central Nervous System, Homeostasis, Humans, Immunity, Innate, Membrane Glycoproteins, Membrane Proteins, Models, Biological, Mutation, Nerve Tissue Proteins, Receptors, Immunologic, Regeneration, Wound Healing, Cytokines, Microglia, Neurodegenerative Diseases, Myeloid Cells, Adaptor Proteins, Signal Transducing, Toll-Like Receptors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: TREM2 in CNS homeostasis and neurodegenerative disease. https://app.cochat.ai/papers/10.1186/s13024-015-0040-9
- The paper
- Painter, M. M., Atagi, Y., Liu, C.-C., Rademakers, R., Xu, H., Fryer, J. D., & Bu, G. (2015). TREM2 in CNS homeostasis and neurodegenerative disease. Molecular Neurodegeneration. https://doi.org/10.1186/s13024-015-0040-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.